We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACRE
1326
Ares Commercial Real Estate
ACRE
$256M
| $1.49M | ﹤0.01% |
143,000
-23,700
| -14% | -$307K |
|
1327
Applied Industrial Technologies
AIT
$12.9B
| $1.49M | ﹤0.01% |
14,500
+2,800
| +24% | +$287K |
|
|
FMTX
1328
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.49M | ﹤0.01% |
74,700
-87,300
| -54% | -$1.15M |
|
1329
Ross Stores
ROST
$80.5B
| $1.48M | ﹤0.01% |
+17,600
| New | +$1.49M |
|
1330
Tactile Systems Technology
TCMD
$626M
| $1.48M | ﹤0.01% |
190,323
-85,177
| -31% | -$710K |
|
|
AERI
1331
DELISTED
Aerie Pharmaceuticals
AERI
| $1.48M | ﹤0.01% |
97,900
+79,600
| +435% | +$925K |
|
1332
Encompass Health
EHC
$11.5B
| $1.48M | ﹤0.01% |
32,700
-7,398
| -18% | -$370K |
|
1333
Ocular Therapeutix
OCUL
$1.85B
| $1.48M | ﹤0.01% |
356,200
-32,900
| -8% | -$166K |
|
1334
KRONOS Worldwide
KRO
$712M
| $1.47M | ﹤0.01% |
157,800
+59,700
| +61% | +$875K |
|
1335
RCI Hospitality Holdings
RICK
$203M
| $1.47M | ﹤0.01% |
22,500
+1,300
| +6% | +$81.1K |
|
1336
Clear Secure
YOU
$5.43B
| $1.46M | ﹤0.01% |
63,900
+45,000
| +238% | +$1.1M |
|
1337
Ryman Hospitality Properties
RHP
$8.58B
| $1.46M | ﹤0.01% |
19,800
+1,300
| +7% | +$109K |
|
1338
Cartesian Therapeutics
RNAC
$225M
| $1.46M | ﹤0.01% |
29,563
+5,156
| +21% | +$283K |
|
1339
CEVA Inc
CEVA
$883M
| $1.45M | ﹤0.01% |
55,372
+11,700
| +27% | +$375K |
|
|
TRQ
1340
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $1.45M | ﹤0.01% |
49,100
-57,080
| -54% | -$1.55M |
|
1341
CorVel
CRVL
$3.14B
| $1.45M | ﹤0.01% |
31,440
+3,000
| +11% | +$156K |
|
1342
Alcon
ALC
$33.7B
| $1.44M | ﹤0.01% |
+24,790
| New | +$1.72M |
|
|
NVMI
1343
Nova
NVMI
$12.8B
| $1.44M | ﹤0.01% |
16,900
-5,400
| -24% | -$530K |
|
1344
AnaptysBio
ANAB
$1.54B
| $1.44M | ﹤0.01% |
56,300
-5,000
| -8% | -$117K |
|
1345
Vanguard Total Stock Market ETF
VTI
$656B
| $1.44M | ﹤0.01% |
8,000
+2,300
| +40% | +$458K |
|
|
BTRS
1346
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $1.43M | ﹤0.01% |
154,500
-138,500
| -47% | -$897K |
|
|
CMPS
1347
Compass Pathways
CMPS
$1.46B
| $1.43M | ﹤0.01% |
133,300
-84,700
| -39% | -$1.27M |
|
|
GATO
1348
DELISTED
Gatos Silver, Inc.
GATO
| $1.43M | ﹤0.01% |
532,800
+102,300
| +24% | +$320K |
|
1349
Global X Cloud Computing ETF
CLOU
$231M
| $1.43M | ﹤0.01% |
89,260
-50,940
| -36% | -$884K |
|
1350
ARS Pharmaceuticals
SPRY
$563M
| $1.43M | ﹤0.01% |
269,800
-156,900
| -37% | -$773K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.